Pharmaceutical formulations of modafinil

Details Pharmaceutical formulations of modafinil Pharmaceutical formulations of modafinil

2007-11-20

2007-11-20

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S451000, C424S452000, C424S464000

Reexamination Certificate

active

10155913

ABSTRACT:
The present invention is related to compositions of modafinil, including compositions of modafinil and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof.

REFERENCES:
patent: 1570994 (1926-01-01), Cook
patent: 4177290 (1979-12-01), Lafon
patent: 4927855 (1990-05-01), Lafon
patent: 5180745 (1993-01-01), Lafon
patent: 5391576 (1995-02-01), Lafon
patent: 5401776 (1995-03-01), Laurent
patent: 5569654 (1996-10-01), Armour et al.
patent: 5612379 (1997-03-01), Laurent
patent: 5618845 (1997-04-01), Grebow et al.
patent: 5843347 (1998-12-01), Nguyen et al.
patent: 5948437 (1999-09-01), Parikh et al.
patent: 6204245 (2001-03-01), Siegel et al.
patent: 6248363 (2001-06-01), Patel et al.
patent: 6267985 (2001-07-01), Chen et al.
patent: 6294192 (2001-09-01), Patel et al.
patent: 6346548 (2002-02-01), Miller et al.
patent: 6451339 (2002-09-01), Patel et al.
patent: 6455588 (2002-09-01), Scammell et al.
patent: 6488164 (2002-12-01), Miller et al.
patent: 6492396 (2002-12-01), Bacon et al.
patent: 6569463 (2003-05-01), Patel et al.
patent: 6670358 (2003-12-01), Bacon et al.
patent: 2001/0034373 (2001-10-01), Miller et al.
patent: W O 9912524 (1999-03-01), None
patent: WO 9912524 (1999-03-01), None
patent: WO 00/37055 (2000-06-01), None
patent: WO 01/13906 (2001-03-01), None
Edgar et al., “Modafinil Induces Wakefulness Without Intensifying Motor Activity or Subsequent Rebound Hypersomnolence in the Rat”, Journal of Pharmacology and Experimental Therapeutics, vol. 283 (2), 1997, p. 757-769.
Hermant et al., “Awakening properties of modafinil: effect on nocuturnal activity in monkeys (Macaca mulatta) after acute and repeated administration.”, Psychopharmacology (Berl), 103(1), 1991, pp. 28-32
Kebbe, “Handbook of Pharmaceutical Excipients”, 3rdEdition, 2000, American Pharmaceutical Association, Pharmaceutical Press, Washington, DC, Sec. 7, pp. 305, 276,102, 528, 87, 433.
Lin et al., “Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.”, Brain Res,. 591 (1992), pp. 319-326.
Panckeri et al. “Modafinil decreases hypersomnolence in the English bulldog, a natural animal model of sleep-disordered breathing” Sleep,19(8), 1996, pp. 626-631.
Shelton, et al., “Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs”, Sleep, 18(10), 1995, pp. 817-826.
Taylor et al., “Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults”, Journal of Child and Adolescent Psychopharmacology, vol. 10, No. 4, Jan. 2000, pp. 311-320.
Touret et al., “Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat”, Neuroscience Letters, 189, 1995, pp. 43-46.

Affiliated with

Also associated with

Rating

Pharmaceutical formulations of modafinil does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations of modafinil, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations of modafinil will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3878032